Doxorubicin, cyclophosphamide in childhood increases risk for second malignancies

Patients who received doxorubicin for childhood cancers faced an increased risk for breast cancer and solid tumors later in life, according to researchers in the Netherlands.

Read more: https://www.healio.com/news/in-the-journals/%7B6985f37b-8ca1-485a-a525-9ce90c6dcfa8%7D/doxorubicin-cyclophosphamide-in-childhood-increases-risk-for-second-malignancies